Gastroenterology & Hepatology (G&H)Early Intervention in Crohn’s Disease

🎓 Expert Commentary / Peer Perspective

Crohn’s disease is a progressive inflammatory condition in which ongoing intestinal injury can lead to irreversible fibrosis, strictures, fistulas, and surgery. Emerging evidence suggests that controlling inflammation early may improve long-term outcomes and reduce cumulative bowel damage.

Clinical Considerations

• Long-term follow-up from the PROFILE trial found lower rates of surgery, hospitalization, and disease progression with early intensive therapy.
• Early biologic treatment has been associated with higher rates of mucosal and transmural healing.
• Fibrotic bowel damage remains difficult to reverse, supporting interest in earlier control of inflammation.
• Risk stratification remains critical because not all patients develop aggressive disease requiring early advanced therapy.

Practice Applications

• Consider disease-risk factors when evaluating newly diagnosed patients.
• Integrate objective markers beyond symptoms when assessing inflammatory burden.
• Monitor evolving evidence regarding transmural healing and disease modification.
• Recognize that treatment timing may influence long-term disease trajectory.